Banner
targets (1)
for drugs
Identification
Name Pyridoxal
Accession Number DB00147 (NUTR00049)
Type small molecule
Groups approved, nutraceutical
Description

The 4-carboxyaldehyde form of vitamin B 6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. [PubChem]
Structure Thumb
Download: MOL | SDF | SMILES | InChI
Display: 2D Structure | 3D Structure
Synonyms
  • PL
  • Pyridoxaldehyde
  • Vitamin B6 hydrochloride
Brand names Not Available
Brand name mixtures Not Available
Categories
  • Dietary supplement
  • Micronutrient
  • Vitamins (Vitamin B Complex)
  • Vitamin B Complex
CAS number 65-22-5
Weight Average: 167.162
Monoisotopic: 167.058243159
Chemical Formula C8H9NO3
InChI Key InChIKey=RADKZDMFGJYCBB-UHFFFAOYSA-N
InChI
InChI=1S/C8H9NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,4,10,12H,3H2,1H3
Plain Text
IUPAC Name
3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde
SMILES
CC1=NC=C(CO)C(C=O)=C1O
Plain Text
Mass Spec Not Available
Taxonomy
Kingdom Organic
Classes
  • Pyridoxals and Derivatives
Substructures
  • Pyridoxals and Derivatives
  • Hydroxy Compounds
  • Pyridines and Derivatives
  • Aldehydes
  • Alcohols and Polyols
  • Heterocyclic compounds
  • Aromatic compounds
  • Imines
  • Phenols and Derivatives
Pharmacology
Indication Pyridoxal is one of the natural forms available of vitamin B6, therefore, it is used for nutritional supplementation and for treating dietary shortage or imbalances.
Pharmacodynamics Pyridoxal principally in the form of the coenzyme pyridoxal 5'-phosphate, is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA).
Mechanism of action Pyridoxal is the precursor to pyridoxal phosphate. Pyridoxal 5'-phosphate is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA).
Absorption Not Available
Volume of distribution Not Available
Protein binding Not Available
Metabolism
Route of elimination Not Available
Half life Not Available
Clearance Not Available
Toxicity Oral LD50 Rat: 2150 mg/kg, Oral LD50 Mouse: 1800 mg/kg
Affected organisms
  • Humans and other mammals
Pathways Not Available
Pharmacoeconomics
Manufacturers Not Available
Packagers
Dosage forms Not Available
Prices
Unit description Cost Unit
Pyridoxal-5-phosphate powder 18.24 USD g
Patents Not Available
Properties
State solid
Melting point 172 oC
Experimental Properties
Property Value Source
water solubility Soluble PhysProp
logP 0 PhysProp
Predicted Properties
Property Value Source
water solubility 1.17e+01 g/l ALOGPS
logP 0.02 ALOGPS
logP 0.18 ChemAxon Molconvert
logS -1.16 ALOGPS
pKa 14.66 ChemAxon Molconvert
hydrogen acceptor count 4 ChemAxon Molconvert
hydrogen donor count 2 ChemAxon Molconvert
polar surface area 70.42 ChemAxon Molconvert
rotatable bond count 2 ChemAxon Molconvert
refractivity 43.87 ChemAxon Molconvert
polarizability 16.28 ChemAxon Molconvert
References
Synthesis Reference Not Available
General Reference Not Available
External Links
Resource Link
KEGG Compound C00250 Link_out
PubChem Compound 1050 Link_out
PubChem Substance 46506282 Link_out
ChemSpider 1021 Link_out
ChEBI 17310 Link_out
ChEMBL 17310 Link_out
HET PXL Link_out
Drug Product Database 0 Link_out
Wikipedia http://en.wikipedia.org/wiki/Pyridoxal Link_out
ATC Codes
  • A11HA06
  • C10AX07
AHFS Codes Not Available
PDB Entries
FDA label Not Available
MSDS show (72.7 KB)
Interactions
Drug Interactions
Drug Interaction
Food Interactions Not Available
Targets

1. Pyridoxal kinase

Pharmacological action: yes

Required for synthesis of pyridoxal-5-phosphate from vitamin B6

Organism class: human
UniProt ID: O00764 Link_out
Gene: PDXK Link_out
Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report Link_out

References:
  1. Tang L, Li MH, Cao P, Wang F, Chang WR, Bach S, Reinhardt J, Ferandin Y, Galons H, Wan Y, Gray N, Meijer L, Jiang T, Liang DC: Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives. J Biol Chem. 2005 Sep 2;280(35):31220-9. Epub 2005 Jun 28. Pubmed
  2. Adams JB, George F, Audhya T: Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements compared to controls not taking supplements. J Altern Complement Med. 2006 Jan-Feb;12(1):59-63. Pubmed
  3. Newman JA, Das SK, Sedelnikova SE, Rice DW: The crystal structure of an ADP complex of Bacillus subtilis pyridoxal kinase provides evidence for the parallel emergence of enzyme activity during evolution. J Mol Biol. 2006 Oct 20;363(2):520-30. Epub 2006 Aug 12. Pubmed
Comments
Drug created on June 13, 2005 07:24 / Updated on November 10, 2010 13:36

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.